Portfolio Holdings Detail for ISIN IE000NITTFF2
| Stock Name / Fund | iShares Russell 1000 Growth UCITS ETF |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | R1GR(USD) AS |
| ETF Ticker | R1GR(USD) Euronext Amsterdam |
Holdings detail for RGEN
| Stock Name | Repligen Corporation |
| Ticker | RGEN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US7599161095 |
| LEI | 54930006QJ0T5AUO1E71 |
Show aggregate RGEN holdings
News associated with RGEN
- Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright
- Repligen (NASDAQ:RGEN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $180.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 38.04% from the stock’s previous close. […] - 2025-05-07 05:58:48
- Repligen (NASDAQ:RGEN) Given New $190.00 Price Target at JPMorgan Chase & Co.
- Repligen (NASDAQ:RGEN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $200.00 to $190.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the biotechnology company’s stock. RGEN has been the subject of several other reports. Wolfe Research raised shares of Repligen […] - 2025-04-30 08:32:52
- Repligen (NASDAQ:RGEN) Upgraded by Wolfe Research to Outperform Rating
- Wolfe Research upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a peer perform rating to an outperform rating in a report published on Tuesday, Marketbeat.com reports. They currently have $160.00 price objective on the biotechnology company’s stock. A number of other research firms have also weighed in on RGEN. Royal Bank of Canada upped […] - 2025-04-30 08:32:47
- StockNews.com Upgrades Repligen (NASDAQ:RGEN) to “Hold”
- Repligen (NASDAQ:RGEN – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. A number of other research analysts have also recently commented on the company. Royal Bank of Canada increased their price target on Repligen from $203.00 to $205.00 and […] - 2025-04-30 07:45:01
- Legal & General Group Plc Lowers Stock Position in Repligen Co. (NASDAQ:RGEN)
- Legal & General Group Plc trimmed its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 6.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,904 shares of the biotechnology company’s stock after selling 5,698 shares during the quarter. Legal & General […] - 2025-04-17 08:57:10
- Federated Hermes Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN)
- Federated Hermes Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 98.4% in the 4th quarter, Holdings Channel reports. The fund owned 5,266 shares of the biotechnology company’s stock after selling 316,555 shares during the period. Federated Hermes Inc.’s holdings in Repligen were worth $758,000 as of its most recent […] - 2025-04-16 08:50:56
- Repligen Co. (NASDAQ:RGEN) Shares Sold by California Public Employees Retirement System
- California Public Employees Retirement System lessened its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.3% in the fourth quarter, HoldingsChannel reports. The fund owned 69,320 shares of the biotechnology company’s stock after selling 4,664 shares during the period. California Public Employees Retirement System’s holdings in Repligen were worth $9,978,000 as of […] - 2025-04-07 08:56:54
- Repligen (NASDAQ:RGEN) Stock Rating Upgraded by StockNews.com
- StockNews.com upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Other equities analysts also recently issued reports about the stock. Canaccord Genuity Group boosted their target price on shares of Repligen from $165.00 to $170.00 and gave the […] - 2025-04-07 05:31:01
- Commonwealth Equity Services LLC Sells 92 Shares of Repligen Co. (NASDAQ:RGEN)
- Commonwealth Equity Services LLC cut its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 6,228 shares of the biotechnology company’s stock after selling 92 shares during the period. Commonwealth Equity Services LLC’s holdings in Repligen were worth $896,000 as of its most recent SEC […] - 2025-04-02 07:34:47
- Vanguard Group Inc. Has $734.25 Million Stake in Repligen Co. (NASDAQ:RGEN)
- Vanguard Group Inc. boosted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,101,090 shares of the biotechnology company’s stock after buying an additional 56,723 shares during the period. Vanguard Group Inc. owned […] - 2025-03-31 08:10:55
- Repligen Co. (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Analysts
- Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price […] - 2025-03-28 06:08:54
- Signaturefd LLC Acquires 124 Shares of Repligen Co. (NASDAQ:RGEN)
- Signaturefd LLC lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 172.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 196 shares of the biotechnology company’s stock after purchasing an additional 124 shares during the quarter. Signaturefd LLC’s holdings in Repligen were worth $28,000 […] - 2025-03-26 08:27:02
- Sum Up The Pieces: JHML Could Be Worth $82
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-20 10:59:44
- Evercore ISI Begins Coverage on Repligen (NASDAQ:RGEN)
- Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report released on Tuesday, Marketbeat Ratings reports. The firm set an “in-line” rating and a $155.00 price target on the biotechnology company’s stock. Evercore ISI’s price objective points to a potential upside of 6.99% from the company’s […] - 2025-03-20 06:48:59
- 21,303 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by Proficio Capital Partners LLC
- Proficio Capital Partners LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 21,303 shares of the biotechnology company’s stock, valued at approximately $3,066,000. A number of other large investors have also […] - 2025-03-19 07:44:45
- M&T Bank Corp Has $427,000 Holdings in Repligen Co. (NASDAQ:RGEN)
- M&T Bank Corp cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,969 shares of the biotechnology company’s stock after selling 197 shares during the period. M&T Bank Corp’s […] - 2025-03-14 08:08:51
- QRG Capital Management Inc. Has $337,000 Position in Repligen Co. (NASDAQ:RGEN)
- QRG Capital Management Inc. reduced its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 35.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,342 shares of the biotechnology company’s stock after selling 1,300 shares during the period. […] - 2025-03-07 09:28:58
- Proficio Capital Partners LLC Acquires New Holdings in Repligen Co. (NASDAQ:RGEN)
- Proficio Capital Partners LLC bought a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 21,303 shares of the biotechnology company’s stock, valued at approximately $3,066,000. Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings […] - 2025-03-06 11:15:38
- Contrasting Repligen (NASDAQ:RGEN) & Compass Therapeutics (NASDAQ:CMPX)
- Repligen (NASDAQ:RGEN – Get Free Report) and Compass Therapeutics (NASDAQ:CMPX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Repligen and Compass […] - 2025-03-06 07:39:57
- Analysts Set Repligen Co. (NASDAQ:RGEN) Target Price at $181.00
- Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target among brokers […] - 2025-03-06 06:45:32
- Truist Financial Corp Cuts Stake in Repligen Co. (NASDAQ:RGEN)
- Truist Financial Corp reduced its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 11.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,953 shares of the biotechnology company’s stock after selling 378 shares during the period. Truist Financial Corp’s holdings in Repligen were worth $425,000 as of its most […] - 2025-03-05 11:34:49
- New York Life Investment Management LLC Has $801,000 Holdings in Repligen Co. (NASDAQ:RGEN)
- New York Life Investment Management LLC cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.6% in the 4th quarter, HoldingsChannel reports. The fund owned 5,562 shares of the biotechnology company’s stock after selling 455 shares during the quarter. New York Life Investment Management LLC’s holdings in Repligen were worth $801,000 […] - 2025-03-05 10:04:59
- Repligen (NASDAQ:RGEN) Downgraded by StockNews.com to Sell
- StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research note released on Friday morning. A number of other equities research analysts also recently weighed in on RGEN. JPMorgan Chase & Co. lifted their price target on shares of Repligen from $190.00 to $200.00 and […] - 2025-02-24 06:40:52
- Repligen (NASDAQ:RGEN) Given New $200.00 Price Target at JPMorgan Chase & Co.
- Repligen (NASDAQ:RGEN – Get Free Report) had its target price boosted by equities research analysts at JPMorgan Chase & Co. from $190.00 to $200.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a […] - 2025-02-23 09:44:58
- New York State Teachers Retirement System Sells 100 Shares of Repligen Co. (NASDAQ:RGEN)
- New York State Teachers Retirement System lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 0.2% during the fourth quarter, Holdings Channel reports. The firm owned 53,932 shares of the biotechnology company’s stock after selling 100 shares during the period. New York State Teachers Retirement System’s holdings in Repligen were worth $7,763,000 at […] - 2025-02-19 09:17:18
- IWF's Underlying Holdings Imply 12% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-17 16:11:41
- Repligen (NASDAQ:RGEN) Coverage Initiated at TD Cowen
- Equities research analysts at TD Cowen initiated coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a note issued to investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $200.00 price target on the biotechnology company’s stock. TD Cowen’s price target points to a potential upside of 33.79% […] - 2025-02-12 06:59:03
- Yousif Capital Management LLC Sells 867 Shares of Repligen Co. (NASDAQ:RGEN)
- Yousif Capital Management LLC lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 5.1% during the 4th quarter, HoldingsChannel reports. The firm owned 16,237 shares of the biotechnology company’s stock after selling 867 shares during the quarter. Yousif Capital Management LLC’s holdings in Repligen were worth $2,337,000 as of its most […] - 2025-02-11 08:40:56
iShares Russell 1000 Growth UCITS ETF RGEN holdings
| Date | Number of RGEN Shares Held | Base Market Value of RGEN Shares | Local Market Value of RGEN Shares | Change in RGEN Shares Held | Change in RGEN Base Value | Current Price per RGEN Share Held | Previous Price per RGEN Share Held |
|---|
| 2025-05-08 (Thursday) | 90 | USD 11,507 | USD 11,507 | 0 | USD 88 | USD 127.856 | USD 126.878 |
| 2025-05-07 (Wednesday) | 90 | USD 11,419 | USD 11,419 | 0 | USD -317 | USD 126.878 | USD 130.4 |
| 2025-05-06 (Tuesday) | 90 | USD 11,736 | USD 11,736 | 0 | USD -947 | USD 130.4 | USD 140.922 |
| 2025-05-05 (Monday) | 90 | USD 12,683 | USD 12,683 | 0 | USD -53 | USD 140.922 | USD 141.511 |
| 2025-05-02 (Friday) | 90 | USD 12,736 | USD 12,736 | 0 | USD 388 | USD 141.511 | USD 137.2 |
| 2025-05-01 (Thursday) | 90 | USD 12,348 | USD 12,348 | 1 | USD 67 | USD 137.2 | USD 137.989 |
| 2025-04-30 (Wednesday) | 89 | USD 12,281 | USD 12,281 | 0 | USD -128 | USD 137.989 | USD 139.427 |
| 2025-04-29 (Tuesday) | 89 | USD 12,409 | USD 12,409 | 0 | USD -374 | USD 139.427 | USD 143.629 |
| 2025-04-28 (Monday) | 89 | USD 12,783 | USD 12,783 | 0 | USD -100 | USD 143.629 | USD 144.753 |
| 2025-04-25 (Friday) | 89 | USD 12,883 | USD 12,883 | 0 | USD -42 | USD 144.753 | USD 145.225 |
| 2025-04-24 (Thursday) | 89 | USD 12,925 | USD 12,925 | 0 | USD 340 | USD 145.225 | USD 141.404 |
| 2025-04-23 (Wednesday) | 89 | USD 12,585 | USD 12,585 | 0 | USD 220 | USD 141.404 | USD 138.933 |
| 2025-04-22 (Tuesday) | 89 | USD 12,365 | USD 12,365 | 3 | USD 1,044 | USD 138.933 | USD 131.64 |
| 2025-04-21 (Monday) | 86 | USD 11,321 | USD 11,321 | 0 | USD 141 | USD 131.64 | USD 130 |
| 2025-04-18 (Friday) | 86 | USD 11,180 | USD 11,180 | 0 | USD 0 | USD 130 | USD 130 |
| 2025-04-17 (Thursday) | 86 | USD 11,180 | USD 11,180 | 0 | USD -181 | USD 130 | USD 132.105 |
| 2025-04-16 (Wednesday) | 86 | USD 11,361 | USD 11,361 | 12 | USD 1,991 | USD 132.105 | USD 126.622 |
| 2025-04-15 (Tuesday) | 74 | USD 9,370 | USD 9,370 | 0 | USD -47 | USD 126.622 | USD 127.257 |
| 2025-04-14 (Monday) | 74 | USD 9,417 | USD 9,417 | 1 | USD 448 | USD 127.257 | USD 122.863 |
| 2025-04-11 (Friday) | 73 | USD 8,969 | USD 8,969 | 0 | USD 560 | USD 122.863 | USD 115.192 |
| 2025-04-10 (Thursday) | 73 | USD 8,409 | USD 8,409 | 1 | USD -508 | USD 115.192 | USD 123.847 |
| 2025-04-09 (Wednesday) | 72 | USD 8,917 | USD 8,917 | 0 | USD 1,077 | USD 123.847 | USD 108.889 |
| 2025-04-08 (Tuesday) | 72 | USD 7,840 | USD 7,840 | 0 | USD -520 | USD 108.889 | USD 116.111 |
| 2025-04-07 (Monday) | 72 | USD 8,360 | USD 8,360 | -3 | USD -36 | USD 116.111 | USD 111.947 |
| 2025-04-04 (Friday) | 75 | USD 8,396 | USD 8,396 | 0 | USD -1,423 | USD 111.947 | USD 130.92 |
| 2025-04-02 (Wednesday) | 75 | USD 9,819 | USD 9,819 | 0 | USD 181 | USD 130.92 | USD 128.507 |
| 2025-04-01 (Tuesday) | 75 | USD 9,638 | USD 9,638 | 0 | USD 95 | USD 128.507 | USD 127.24 |
| 2025-03-31 (Monday) | 75 | USD 9,543 | USD 9,543 | 1 | USD -329 | USD 127.24 | USD 133.405 |
| 2025-03-28 (Friday) | 74 | USD 9,872 | USD 9,872 | 0 | USD -275 | USD 133.405 | USD 137.122 |
| 2025-03-27 (Thursday) | 74 | USD 10,147 | USD 10,147 | 5 | USD 526 | USD 137.122 | USD 139.435 |
| 2025-03-26 (Wednesday) | 69 | USD 9,621 | USD 9,621 | 0 | USD -174 | USD 139.435 | USD 141.957 |
| 2025-03-25 (Tuesday) | 69 | USD 9,795 | USD 9,795 | 0 | USD -220 | USD 141.957 | USD 145.145 |
| 2025-03-24 (Monday) | 69 | USD 10,015 | USD 10,015 | 0 | USD 354 | USD 145.145 | USD 140.014 |
| 2025-03-21 (Friday) | 69 | USD 9,661 | USD 9,661 | 0 | USD 47 | USD 140.014 | USD 139.333 |
| 2025-03-20 (Thursday) | 69 | USD 9,614 | USD 9,614 | 0 | USD -383 | USD 139.333 | USD 144.884 |
| 2025-03-19 (Wednesday) | 69 | USD 9,997 | USD 9,997 | 1 | USD 182 | USD 144.884 | USD 144.338 |
| 2025-03-18 (Tuesday) | 68 | USD 9,815 | USD 9,815 | 1 | USD -423 | USD 144.338 | USD 152.806 |
| 2025-03-17 (Monday) | 67 | USD 10,238 | USD 10,238 | 0 | USD 146 | USD 152.806 | USD 150.627 |
| 2025-03-14 (Friday) | 67 | USD 10,092 | USD 10,092 | 0 | USD 549 | USD 150.627 | USD 142.433 |
| 2025-03-13 (Thursday) | 67 | USD 9,543 | USD 9,543 | 0 | USD -197 | USD 142.433 | USD 145.373 |
| 2025-03-12 (Wednesday) | 67 | USD 9,740 | USD 9,740 | 0 | USD -118 | USD 145.373 | USD 147.134 |
| 2025-03-11 (Tuesday) | 67 | USD 9,858 | USD 9,858 | 0 | USD 680 | USD 147.134 | USD 136.985 |
| 2025-03-10 (Monday) | 67 | USD 9,178 | USD 9,178 | 0 | USD -1,254 | USD 136.985 | USD 155.701 |
| 2025-03-07 (Friday) | 67 | USD 10,432 | USD 10,432 | 0 | USD -132 | USD 155.701 | USD 157.672 |
| 2025-03-05 (Wednesday) | 67 | USD 10,564 | USD 10,564 | 0 | USD 192 | USD 157.672 | USD 154.806 |
| 2025-03-04 (Tuesday) | 67 | USD 10,372 | USD 10,372 | 0 | USD -38 | USD 154.806 | USD 155.373 |
| 2025-03-03 (Monday) | 67 | USD 10,410 | USD 10,410 | 0 | USD -260 | USD 155.373 | USD 159.254 |
| 2025-02-28 (Friday) | 67 | USD 10,670 | USD 10,670 | 0 | USD 182 | USD 159.254 | USD 156.537 |
| 2025-02-27 (Thursday) | 67 | USD 10,488 | USD 10,488 | 1 | USD -257 | USD 156.537 | USD 162.803 |
| 2025-02-26 (Wednesday) | 66 | USD 10,745 | USD 10,745 | 0 | USD 88 | USD 162.803 | USD 161.47 |
| 2025-02-25 (Tuesday) | 66 | USD 10,657 | USD 10,657 | -1 | USD -381 | USD 161.47 | USD 164.746 |
| 2025-02-24 (Monday) | 67 | USD 11,038 | USD 11,038 | -1 | USD 227 | USD 164.746 | USD 158.985 |
| 2025-02-21 (Friday) | 68 | USD 10,811 | USD 10,811 | 0 | USD -251 | USD 158.985 | USD 162.676 |
| 2025-02-20 (Thursday) | 68 | USD 11,062 | USD 11,062 | 0 | USD 812 | USD 162.676 | USD 150.735 |
| 2025-02-19 (Wednesday) | 68 | USD 10,250 | USD 10,250 | 0 | USD 378 | USD 150.735 | USD 145.176 |
| 2025-02-18 (Tuesday) | 68 | USD 9,872 | USD 9,872 | 0 | USD -119 | USD 145.176 | USD 146.926 |
| 2025-02-17 (Monday) | 68 | USD 9,991 | USD 9,991 | 0 | USD 0 | USD 146.926 | USD 146.926 |
| 2025-02-14 (Friday) | 68 | USD 9,991 | USD 9,991 | 0 | USD 51 | USD 146.926 | USD 146.176 |
| 2025-02-13 (Thursday) | 68 | USD 9,940 | USD 9,940 | 0 | USD 31 | USD 146.176 | USD 145.721 |
| 2025-02-12 (Wednesday) | 68 | USD 9,909 | USD 9,909 | 0 | USD -256 | USD 145.721 | USD 149.485 |
| 2025-02-11 (Tuesday) | 68 | USD 10,165 | USD 10,165 | 0 | USD -297 | USD 149.485 | USD 153.853 |
| 2025-02-10 (Monday) | 68 | USD 10,462 | USD 10,462 | 0 | USD -149 | USD 153.853 | USD 156.044 |
| 2025-02-07 (Friday) | 68 | USD 10,611 | USD 10,611 | 0 | USD -395 | USD 156.044 | USD 161.853 |
| 2025-02-06 (Thursday) | 68 | USD 11,006 | USD 11,006 | 1 | USD 157 | USD 161.853 | USD 161.925 |
| 2025-02-05 (Wednesday) | 67 | USD 10,849 | USD 10,849 | 1 | USD 288 | USD 161.925 | USD 160.015 |
| 2025-02-04 (Tuesday) | 66 | USD 10,561 | USD 10,561 | 0 | USD 10 | USD 160.015 | USD 159.864 |
| 2025-02-03 (Monday) | 66 | USD 10,551 | USD 10,551 | 0 | USD -419 | USD 159.864 | USD 166.212 |
| 2025-01-31 (Friday) | 66 | USD 10,970 | USD 10,970 | 0 | USD -87 | USD 166.212 | USD 167.53 |
| 2025-01-30 (Thursday) | 66 | USD 11,057 | USD 11,057 | 0 | USD -123 | USD 167.53 | USD 169.394 |
| 2025-01-29 (Wednesday) | 66 | USD 11,180 | USD 11,180 | 0 | USD -320 | USD 169.394 | USD 174.242 |
| 2025-01-28 (Tuesday) | 66 | USD 11,500 | USD 11,500 | 0 | USD 411 | USD 174.242 | USD 168.015 |
| 2025-01-27 (Monday) | 66 | USD 11,089 | USD 11,089 | 0 | USD 140 | USD 168.015 | USD 165.894 |
| 2025-01-24 (Friday) | 66 | USD 10,949 | USD 10,949 | 0 | USD -132 | USD 165.894 | USD 167.894 |
| 2025-01-23 (Thursday) | 66 | USD 11,081 | USD 11,081 | 0 | USD 70 | USD 167.894 | USD 166.833 |
| 2025-01-22 (Wednesday) | 66 | USD 11,011 | USD 11,011 | | | | |
| 2025-01-21 (Tuesday) | 64 | USD 10,747 | USD 10,747 | | | | |
| 2025-01-20 (Monday) | 60 | USD 9,631 | USD 9,631 | | | | |
| 2025-01-17 (Friday) | 60 | USD 9,631 | USD 9,631 | | | | |
| 2025-01-16 (Thursday) | 60 | USD 9,771 | USD 9,771 | | | | |
| 2025-01-15 (Wednesday) | 57 | USD 8,966 | USD 8,966 | | | | |
| 2025-01-14 (Tuesday) | 57 | USD 8,923 | USD 8,923 | | | | |
| 2025-01-13 (Monday) | 57 | USD 9,031 | USD 9,031 | | | | |
| 2025-01-10 (Friday) | 57 | USD 8,827 | USD 8,827 | | | | |
| 2025-01-09 (Thursday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2025-01-09 (Thursday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2025-01-09 (Thursday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2025-01-08 (Wednesday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2025-01-08 (Wednesday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2025-01-08 (Wednesday) | 57 | USD 8,818 | USD 8,818 | | | | |
| 2024-12-10 (Tuesday) | 51 | USD 7,749 | USD 7,749 | 1 | USD 13 | USD 151.941 | USD 154.72 |
| 2024-12-09 (Monday) | 50 | USD 7,736 | USD 7,736 | 1 | USD 425 | USD 154.72 | USD 149.204 |
| 2024-12-06 (Friday) | 49 | USD 7,311 | USD 7,311 | 0 | USD 340 | USD 149.204 | USD 142.265 |
| 2024-12-05 (Thursday) | 49 | USD 6,971 | USD 6,971 | 0 | USD -334 | USD 142.265 | USD 149.082 |
| 2024-12-04 (Wednesday) | 49 | USD 7,305 | USD 7,305 | 0 | USD 28 | USD 149.082 | USD 148.51 |
| 2024-12-03 (Tuesday) | 49 | USD 7,277 | USD 7,277 | 0 | USD -96 | USD 148.51 | USD 150.469 |
| 2024-12-02 (Monday) | 49 | USD 7,373 | USD 7,373 | -1 | USD -154 | USD 150.469 | USD 150.54 |
| 2024-11-29 (Friday) | 50 | USD 7,527 | USD 7,527 | 0 | USD 27 | USD 150.54 | USD 150 |
| 2024-11-28 (Thursday) | 50 | USD 7,500 | USD 7,500 | 0 | USD 0 | USD 150 | USD 150 |
| 2024-11-27 (Wednesday) | 50 | USD 7,500 | USD 7,500 | 0 | USD 163 | USD 150 | USD 146.74 |
| 2024-11-26 (Tuesday) | 50 | USD 7,337 | USD 7,337 | 0 | USD 34 | USD 146.74 | USD 146.06 |
| 2024-11-25 (Monday) | 50 | USD 7,303 | USD 7,303 | 1 | USD 317 | USD 146.06 | USD 142.571 |
| 2024-11-22 (Friday) | 49 | USD 6,986 | USD 6,986 | 0 | USD 40 | USD 142.571 | USD 141.755 |
| 2024-11-21 (Thursday) | 49 | USD 6,946 | USD 6,946 | 0 | USD 140 | USD 141.755 | USD 138.898 |
| 2024-11-20 (Wednesday) | 49 | USD 6,806 | USD 6,806 | 0 | USD 510 | USD 138.898 | USD 128.49 |
| 2024-11-19 (Tuesday) | 49 | USD 6,296 | USD 6,296 | 0 | USD 249 | USD 128.49 | USD 123.408 |
| 2024-11-18 (Monday) | 49 | USD 6,047 | USD 6,047 | 0 | USD -1,234 | USD 123.408 | USD 148.592 |
| 2024-11-12 (Tuesday) | 49 | USD 7,281 | USD 7,281 | 0 | USD 387 | USD 148.592 | USD 140.694 |
| 2024-11-08 (Friday) | 49 | USD 6,894 | USD 6,894 | 3 | USD 276 | USD 140.694 | USD 143.87 |
| 2024-11-07 (Thursday) | 46 | USD 6,618 | USD 6,618 | 0 | USD -95 | USD 143.87 | USD 145.935 |
| 2024-11-06 (Wednesday) | 46 | USD 6,713 | USD 6,713 | 1 | USD 145 | USD 145.935 | USD 145.956 |
| 2024-11-05 (Tuesday) | 45 | USD 6,568 | USD 6,568 | 0 | USD 289 | USD 145.956 | USD 139.533 |
| 2024-11-04 (Monday) | 45 | USD 6,279 | USD 6,279 | 0 | USD 42 | USD 139.533 | USD 138.6 |
| 2024-11-01 (Friday) | 45 | USD 6,237 | USD 6,237 | 0 | USD 195 | USD 138.6 | USD 134.267 |
| 2024-10-31 (Thursday) | 45 | USD 6,042 | USD 6,042 | 0 | USD -95 | USD 134.267 | USD 136.378 |
| 2024-10-30 (Wednesday) | 45 | USD 6,137 | USD 6,137 | 1 | USD 203 | USD 136.378 | USD 134.864 |
| 2024-10-29 (Tuesday) | 44 | USD 5,934 | USD 5,934 | 0 | USD -103 | USD 134.864 | USD 137.205 |
| 2024-10-28 (Monday) | 44 | USD 6,037 | USD 6,037 | 0 | USD 77 | USD 137.205 | USD 135.455 |
| 2024-10-25 (Friday) | 44 | USD 5,960 | USD 5,960 | 0 | USD 12 | USD 135.455 | USD 135.182 |
| 2024-10-24 (Thursday) | 44 | USD 5,948 | USD 5,948 | 0 | USD -101 | USD 135.182 | USD 137.477 |
| 2024-10-23 (Wednesday) | 44 | USD 6,049 | USD 6,049 | 0 | USD -293 | USD 137.477 | USD 144.136 |
| 2024-10-22 (Tuesday) | 44 | USD 6,342 | USD 6,342 | -18 | USD -2,909 | USD 144.136 | USD 149.21 |
| 2024-10-21 (Monday) | 62 | USD 9,251 | USD 9,251 | 0 | USD 140 | USD 149.21 | USD 146.952 |
| 2024-10-18 (Friday) | 62 | USD 9,111 | USD 9,111 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of RGEN by Blackrock for IE000NITTFF2
Show aggregate share trades of RGEN| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-05-01 | BUY | 1 | | | 137.200* | | 144.77 |
| 2025-04-22 | BUY | 3 | | | 138.933* | | 145.00 |
| 2025-04-16 | BUY | 12 | | | 132.105* | | 145.63 |
| 2025-04-14 | BUY | 1 | | | 127.257* | | 146.05 |
| 2025-04-10 | BUY | 1 | | | 115.192* | | 146.68 |
| 2025-04-07 | SELL | -3 | | | 116.111* | | 147.78 Profit of 443 on sale |
| 2025-03-31 | BUY | 1 | | | 127.240* | | 148.95 |
| 2025-03-27 | BUY | 5 | | | 137.122* | | 149.30 |
| 2025-03-19 | BUY | 1 | | | 144.884* | | 149.94 |
| 2025-03-18 | BUY | 1 | | | 144.338* | | 150.02 |
| 2025-02-27 | BUY | 1 | | | 156.537* | | 149.77 |
| 2025-02-25 | SELL | -1 | | | 161.470* | | 149.33 Profit of 149 on sale |
| 2025-02-24 | SELL | -1 | | | 164.746* | | 149.05 Profit of 149 on sale |
| 2025-02-06 | BUY | 1 | | | 161.853* | | 148.21 |
| 2025-02-05 | BUY | 1 | | | 161.925* | | 147.88 |
| 2024-12-10 | BUY | 1 | | | 151.941* | | 142.50 |
| 2024-12-09 | BUY | 1 | | | 154.720* | | 142.11 |
| 2024-12-02 | SELL | -1 | | | 150.469* | | 140.99 Profit of 141 on sale |
| 2024-11-25 | BUY | 1 | | | 146.060* | | 139.17 |
| 2024-11-08 | BUY | 3 | | | 140.694* | | 139.86 |
| 2024-11-06 | BUY | 1 | | | 145.935* | | 139.02 |
| 2024-10-30 | BUY | 1 | | | 136.378* | | 139.08 |
| 2024-10-22 | SELL | -18 | | | 144.136* | | 149.21 Profit of 2,686 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of RGEN
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-05-09 | 131,880 | 348 | 214,436 | 61.5% |
| 2025-05-08 | 118,054 | 142 | 207,199 | 57.0% |
| 2025-05-07 | 241,492 | 128 | 625,394 | 38.6% |
| 2025-05-06 | 387,400 | 8,111 | 557,132 | 69.5% |
| 2025-05-05 | 205,381 | 74 | 294,241 | 69.8% |
| 2025-05-02 | 147,125 | 42 | 231,236 | 63.6% |
| 2025-05-01 | 101,145 | 863 | 176,124 | 57.4% |
| 2025-04-30 | 264,416 | 3 | 381,536 | 69.3% |
| 2025-04-29 | 615,336 | 6,749 | 1,017,640 | 60.5% |
| 2025-04-28 | 202,875 | 21 | 421,684 | 48.1% |
| 2025-04-25 | 108,763 | 33 | 191,684 | 56.7% |
| 2025-04-24 | 143,013 | 652 | 215,764 | 66.3% |
| 2025-04-23 | 159,366 | 2,750 | 264,036 | 60.4% |
| 2025-04-22 | 320,586 | 43 | 523,174 | 61.3% |
| 2025-04-21 | 194,640 | 89 | 273,093 | 71.3% |
| 2025-04-17 | 193,530 | 0 | 296,855 | 65.2% |
| 2025-04-16 | 362,840 | 5,845 | 481,910 | 75.3% |
| 2025-04-15 | 172,453 | 2,278 | 295,307 | 58.4% |
| 2025-04-14 | 194,857 | 26 | 273,577 | 71.2% |
| 2025-04-11 | 207,698 | 6,355 | 447,112 | 46.5% |
| 2025-04-10 | 201,992 | 1,134 | 344,458 | 58.6% |
| 2025-04-09 | 175,007 | 1,537 | 521,364 | 33.6% |
| 2025-04-08 | 220,092 | 0 | 470,542 | 46.8% |
| 2025-04-07 | 352,468 | 10,595 | 676,954 | 52.1% |
| 2025-04-04 | 305,876 | 7,142 | 711,479 | 43.0% |
| 2025-04-03 | 150,601 | 38 | 354,275 | 42.5% |
| 2025-04-02 | 98,012 | 21 | 237,527 | 41.3% |
| 2025-04-01 | 95,693 | 29 | 215,867 | 44.3% |
| 2025-03-31 | 155,533 | 0 | 397,899 | 39.1% |
| 2025-03-28 | 117,697 | 105 | 298,183 | 39.5% |
| 2025-03-27 | 40,997 | 0 | 84,901 | 48.3% |
| 2025-03-26 | 52,650 | 505 | 128,591 | 40.9% |
| 2025-03-25 | 69,212 | 0 | 128,091 | 54.0% |
| 2025-03-24 | 75,401 | 0 | 151,772 | 49.7% |
| 2025-03-21 | 66,023 | 0 | 143,895 | 45.9% |
| 2025-03-20 | 62,205 | 69 | 137,194 | 45.3% |
| 2025-03-19 | 69,792 | 445 | 239,863 | 29.1% |
| 2025-03-18 | 145,149 | 0 | 543,157 | 26.7% |
| 2025-03-17 | 90,286 | 40 | 160,988 | 56.1% |
| 2025-03-14 | 65,893 | 14 | 126,352 | 52.2% |
| 2025-03-13 | 96,126 | 6,043 | 180,017 | 53.4% |
| 2025-03-12 | 91,594 | 0 | 207,770 | 44.1% |
| 2025-03-11 | 143,843 | 2,070 | 317,568 | 45.3% |
| 2025-03-10 | 208,206 | 152 | 543,556 | 38.3% |
| 2025-03-07 | 71,946 | 0 | 355,042 | 20.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.